211 related articles for article (PubMed ID: 11755958)
1. Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitro.
Mattsson C; Menschik-Lundin A; Nylander S; Gyzander E; Deinum J
Thromb Res; 2001 Dec; 104(6):475-86. PubMed ID: 11755958
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelial cell-mediated generation of activated protein C by direct and antithrombin-dependent thrombin inhibitors.
Linder R; Frebelius S; Jansson K; Swedenborg J
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):139-46. PubMed ID: 12632023
[TBL] [Abstract][Full Text] [Related]
3. Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C.
Linder R; Blombäck M; Egberg N; Grip L
Thromb Res; 1999 Jul; 95(2):117-25. PubMed ID: 10418800
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
Furugohri T; Sugiyama N; Morishima Y; Shibano T
Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
[TBL] [Abstract][Full Text] [Related]
5. The influence of direct and antithrombin-dependent thrombin inhibitors on the procoagulant and anticoagulant effects of thrombin.
Linder R; Frebelius S; Grip L; Swedenborg J
Thromb Res; 2003 Jun; 110(4):221-6. PubMed ID: 14512086
[TBL] [Abstract][Full Text] [Related]
6. Direct thrombin inhibitors, but not the direct factor Xa inhibitor rivaroxaban, increase tissue factor-induced hypercoagulability in vitro and in vivo.
Perzborn E; Heitmeier S; Buetehorn U; Laux V
J Thromb Haemost; 2014 Jul; 12(7):1054-65. PubMed ID: 24766850
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium on the energetics of thrombin-thrombomodulin interaction and its relevance for protein C hydrolysis.
De Cristofaro R; Picozzi M; Morosetti R; Landolfi R
J Mol Biol; 1996 Apr; 258(1):190-200. PubMed ID: 8613987
[TBL] [Abstract][Full Text] [Related]
8. Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors.
Yang L; Rezaie AR
Thromb Haemost; 2007 Jun; 97(6):899-906. PubMed ID: 17549291
[TBL] [Abstract][Full Text] [Related]
9. A direct thrombin inhibitor suppresses protein C activation and factor Va degradation in human plasma: Possible mechanisms of paradoxical enhancement of thrombin generation.
Kamisato C; Furugohri T; Morishima Y
Thromb Res; 2016 May; 141():77-83. PubMed ID: 26974491
[TBL] [Abstract][Full Text] [Related]
10. Role of Leu99 of thrombin in determining the P2 specificity of serpins.
Rezaie AR
Biochemistry; 1997 Jun; 36(24):7437-46. PubMed ID: 9200692
[TBL] [Abstract][Full Text] [Related]
11. Energetics of thrombin-thrombomodulin interaction.
Vindigni A; White CE; Komives EA; Di Cera E
Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
[TBL] [Abstract][Full Text] [Related]
12. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
[TBL] [Abstract][Full Text] [Related]
13. Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector.
De Cristofaro R; Picozzi M; De Candia E; Rocca B; Landolfi R
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):49-53. PubMed ID: 7646471
[TBL] [Abstract][Full Text] [Related]
14. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
Hortin GL; Trimpe BL
J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
[TBL] [Abstract][Full Text] [Related]
15. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va.
Van Walderveen MC; Berry LR; Atkinson HM; Chan AK
Thromb Haemost; 2010 May; 103(5):910-9. PubMed ID: 20216984
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c.
Aritomi M; Watanabe N; Ohishi R; Gomi K; Kiyota T; Yamamoto S; Ishida T; Maruyama I
Thromb Haemost; 1993 Sep; 70(3):418-22. PubMed ID: 8259541
[TBL] [Abstract][Full Text] [Related]
17. Mutagenesis studies toward understanding the mechanism of the cofactor function of thrombomodulin.
Rezaie AR; Yang L
Biophys Chem; 2005 Oct; 117(3):255-61. PubMed ID: 15970373
[TBL] [Abstract][Full Text] [Related]
18. Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin.
Gerlitz B; Grinnell BW
J Biol Chem; 1996 Sep; 271(37):22285-8. PubMed ID: 8798383
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma.
Mohri M; Suzuki M; Sugimoto E; Sata M; Yamamoto S; Maruyama I
Thromb Haemost; 1998 Dec; 80(6):925-9. PubMed ID: 9869162
[TBL] [Abstract][Full Text] [Related]
20. Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.
Bates SM; Weitz JI
Am J Cardiol; 1998 Oct; 82(8B):12P-18P. PubMed ID: 9809887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
